Grete Roede og Navamedic lanserer nytt vektreduksjonskonsept: Lettere steg Publisert: 29.12.2025 Oslo, December 9, 2025 – Navamedic ASA Introduces Flexilev[®] in OraFID[®]: Enhancing Parkinson’s Care with Simplified and Precise Dosing for Personalized Treatment Publisert: 09.12.2025 Ny svensk Novusundersökning: Så vanligt är känslomässigt ätande vid övervikt Publisert: 03.12.2025 Navamedic ASA: Navamedic extends its business into Germany together with Evolsin Medical Publisert: 17.10.2025 Navamedic ASA launches Eroxon® in Denmark Publisert: 05.05.2025 Navamedic Welcomes CHMP’s Positive Review of Mysimba’s Cardiovascular Safety Publisert: 02.04.2025 FørsteForrige12345NesteSiste
Oslo, December 9, 2025 – Navamedic ASA Introduces Flexilev[®] in OraFID[®]: Enhancing Parkinson’s Care with Simplified and Precise Dosing for Personalized Treatment Publisert: 09.12.2025
Navamedic ASA: Navamedic extends its business into Germany together with Evolsin Medical Publisert: 17.10.2025
